# OnCo record nct05671510 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05671510/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05671510", "NCT05671510" ;
  schema:name "ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors"@en ;
  schema:alternateName "PRESERVE-003"@en ;
  schema:description "A phase 3 trial testing Gotistobart in non-small-cell lung cancer, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05671510/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05671510> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2023-06-28" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:drugs <https://onco.cc/drugs/gotistobart/> ;
  onco:companies <https://onco.cc/companies/oncoc4/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-nct05671510-nat-med-2026/> .